High flow nasal cannulae for respiratory support in adult intensive care patients

  • Protocol
  • Intervention

Authors

  • Amanda Corley,

    Corresponding author
    1. The Prince Charles Hospital, Critical Care Research Group, Intensive Care Services, Chermside, Queensland, Australia
    2. Griffith University, NHMRC Centre of Research Excellence in Nursing, Centre for Health Practice Innovation, Menzies Health Institute Queensland, Brisbane, Australia
    • Amanda Corley, Critical Care Research Group, Intensive Care Services, The Prince Charles Hospital, Level 5, CSB, Rode Rd, Chermside, Queensland, 4032, Australia. amanda.corley@health.qld.gov.au.

    Search for more papers by this author
  • Claire M Rickard,

    1. Griffith University, NHMRC Centre of Research Excellence in Nursing, Centre for Health Practice Innovation, Menzies Health Institute Queensland, Brisbane, Australia
    Search for more papers by this author
  • Leanne M Aitken,

    1. Griffith University, NHMRC Centre of Research Excellence in Nursing, Centre for Health Practice Innovation, Menzies Institute of Health Queensland, Brisbane, Queensland, Australia
    2. Princess Alexandra Hospital, Intensive Care Unit, Woolloongabba, Queensland, Australia
    Search for more papers by this author
  • Amy Johnston,

    1. Griffith University, School of Nursing and Midwifery, Research Centre for Clinical and Community Practice Innovation, Nathan, Queensland, Australia
    Search for more papers by this author
  • Adrian Barnett,

    1. Queensland University of Technology, Institute of Health and Biomedical Innovation, School of Public Health and Social Work, Kelvin Grove, Queensland, Australia
    Search for more papers by this author
  • John F Fraser

    1. The Prince Charles Hospital, Critical Care Research Group, Intensive Care Services, Chermside, Queensland, Australia
    2. University of Queensland, St Lucia, Queensland, Australia
    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

We will evaluate studies which include patients 16 years and over admitted to the ICU and who require treatment with HFNC. We will assess the safety and efficacy of HFNC compared with the comparator interventions in terms of failure of treatment, mortality, adverse events, duration of respiratory support, hospital and ICU length of stay, respiratory effects, patient reported outcomes, and cost of treatment.